492 related articles for article (PubMed ID: 10880388)
1. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF
J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
[TBL] [Abstract][Full Text] [Related]
4. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
Sisson TH; Hattori N; Xu Y; Simon RH
Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
[TBL] [Abstract][Full Text] [Related]
6. The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.
Sato J; Schorey J; Ploplis VA; Haalboom E; Krahule L; Castellino FJ
Am J Pathol; 2003 Aug; 163(2):517-31. PubMed ID: 12875972
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.
Eitzman DT; McCoy RD; Zheng X; Fay WP; Shen T; Ginsburg D; Simon RH
J Clin Invest; 1996 Jan; 97(1):232-7. PubMed ID: 8550840
[TBL] [Abstract][Full Text] [Related]
8. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
10. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
[TBL] [Abstract][Full Text] [Related]
12. Urokinase Plasminogen Activator Overexpression Reverses Established Lung Fibrosis.
Horowitz JC; Tschumperlin DJ; Kim KK; Osterholzer JJ; Subbotina N; Ajayi IO; Teitz-Tennenbaum S; Virk A; Dotson M; Liu F; Sicard D; Jia S; Sisson TH
Thromb Haemost; 2019 Dec; 119(12):1968-1980. PubMed ID: 31705517
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice.
Jögi A; Pass J; Høyer-Hansen G; Lund LR; Nielsen BS; Danø K; Rømer J
J Thromb Haemost; 2007 Sep; 5(9):1936-44. PubMed ID: 17723133
[TBL] [Abstract][Full Text] [Related]
14. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.
Bhandary YP; Shetty SK; Marudamuthu AS; Gyetko MR; Idell S; Gharaee-Kermani M; Shetty RS; Starcher BC; Shetty S
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L463-73. PubMed ID: 22140072
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice.
Kawao N; Nagai N; Tamura Y; Okada K; Yano M; Suzuki Y; Umemura K; Ueshima S; Matsuo O
Thromb Haemost; 2011 May; 105(5):892-900. PubMed ID: 21301782
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic regulation in human endothelial cells by fibrinolytic factors.
Fukao H; Matsuo O
Semin Thromb Hemost; 2000; 26(1):33-8. PubMed ID: 10805279
[TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic system in neoplasia.
Bell WR
Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.
Nakanishi T; Hasegawa Y; Mimura R; Wakayama T; Uetoko Y; Komori H; Akanuma S; Hosoya K; Tamai I
PLoS One; 2015; 10(4):e0123895. PubMed ID: 25923111
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
